Certain Ordinary Shares of Regencell Bioscience Holdings Limited are subject to a Lock-Up Agreement Ending on 12-JAN-2022. These Ordinary Shares will be under lockup for 181 days starting from 15-JUL-2021 to 12-JAN-2022. Details: The directors, officers any other holders of three percent (3.0%) or more of the outstanding ordinary share as of the effective date of the Registration Statement (and all holders of securities exercisable for or convertible into shares of ordinary share) shall enter into customary lock-up agreements in favor of Maxim pursuant to which such persons and entities shall agree, for a period of one hundred and eighty days (180) after the IPO is completed, that they shall neither offer, issue, sell, contract to sell, encumber, grant any option for the sale of or otherwise dispose of any securities of the Company without Maxim’s prior written consent, including the issuance of shares of Ordinary Share upon the exercise of currently outstanding options approved by Maxim.